                                                          RESEARCH ARTICLE


                                                          Targeting Ergosterol Biosynthesis                                                           Leishmania donovani: Essentiality Sterol
                                                          14alpha-demethylase
 




    OPEN ACCESS                                           Abstract
Citation: McCall L  El Aroussi  Choi JY, Vieira DF,
                                                          Leishmania protozoan parasites (Trypanosomatidae family) causative agents cu- Muylder G, Johnston JB, et al. (2015) Targeting
Ergosterol Biosynthesis Leishmania donovani:           taneous, mucocutaneous visceral leishmaniasis worldwide. diseases Essentiality Sterol 14alpha-demethylase. PLoS          associated significant morbidity mortality, adequate treatments avail-
Negl Trop Dis 9(3): e0003588. doi:10.1371/journal.        able. Sterol 14alpha-demethylase (CYP51) parasite sterol biosynthesis pathway pntd.0003588
                                                          focus considerable novel drug target Leishmania.  Editor: Alain Debrabant, United States Food           essentiality Leishmania donovani determined.  use dual biologi-
Drug Administration, UNITED STATES
                                                          cal pharmacological approach demonstrate CYP51 indispensable L. dono-
Received: December 10, 2014                               vani. facilitated knockout approach chromosomal CYP51 genes Accepted: February 3, 2015                                knocked presence episomal complementation episome
Published: March 13, 2015                                 lost parasite negative selection. addition, treated wild-
                                                          type L. donovani CYP51-deficient strains 4-aminopyridyl-based inhibitors 
Copyright: © 2015 McCall et al. open
access article distributed terms         signed specifically Trypanosoma cruzi CYP51. potency lower T. cruzi,
Creative Commons Attribution License, permits       inhibitors increased efficacy parasites lacking CYP51 allele compared unrestricted use, distribution, reproduction   complemented parasites, indicating inhibition parasite growth CYP51-specific
medium, provided original author source credited.
                                                          mechanism confirming essentiality CYP51 L. donovani. Overall, results pro-
                                                          vide support development CYP51 inhibitors treatment D
                                                          visceral leishmaniasis.


gov/) European Union Seventh                     Visceral leishmaniasis second lethal parasitic infection malaria. Framework Programme (602773-KINDRED JHM,                 forms leishmaniasis cause significant morbidity.  treatments
http://cordis.europa.eu/fp7/home_en.html).              available, cause severe effects associated development funders role study design, data collection




                                                                                                              Essentiality Leishmania donovani CYP51


 analysis, decision publish, preparation manuscript.                                          resistance. key difference mammalian cells Leishmania parasites type
Competing Interests: authors declared           sterol membranes: mammalian cell membranes contain cholesterol, Leish- competing interests exist.                       mania parasites use ergosterol. considerable develop-
                                                         ing inhibitors sterol biosynthesis pathways target Leishmania parasites. Sterol
                                                         14alpha-demethylase (CYP51) enzymes sterol biosynthesis pathway,
                                                         target significant drug development research Leishmania. use dou-
                                                         ble approach determine gene essential Leishmania donovani, caus-
                                                         ative agent visceral leishmaniasis. demonstrate gene knockout drug
                                                         targeting approaches loss inhibition CYP51 inhibits L. donovani growth.                                                          results validate CYP51 drug target L. donovani support work develop
                                                         CYP51-directed therapies visceral leishmaniasis.




                                                       Introduction
                                                       Leishmania vector-borne protozoan parasites. digenetic lifecycle; promasti-
                                                       gotes transmitted sandfly vector mammalian host, taken                                                        phagocytic cells differentiate amastigote stage macrophage phagolyso-
                                                       sosme. Amastigotes proliferate phagolysosome taken sandfly
                                                       subsequent bloodmeal. sandfly gut, amastigotes differentiate                                                        promastigotes, completing parasite lifecycle [1].
                                                           Leishmania parasites cause range disease manifestations: cutaneous leishmaniasis                                                        lesions develop site sandfly bite, mucocutaneous leishmaniasis destruc-
                                                       tion mucosal tissues nose, mouth throat, visceral leishmaniasis                                                        parasites disseminate liver, bone marrow spleen. Visceral leishmaniasis                                                        lethal form disease. associated high fever, hepatosplenomegaly pancytope-
                                                       nia [1]. infecting species Leishmania major determinant disease manifestation;
                                                       parasites Leishmania donovani species complex main causes visceral leish-
                                                       maniasis, species, including Leishmania major species complex, cause cutane-
                                                       ous manifestations [2,3].
                                                           Leishmania parasites distributed tropical subtropical regions world.
                                                       350 million people live endemic areas risk developing disease, 12 mil-
                                                       lion people currently infected [4]. Overall, 1.6 million new cases year [5], associat-
                                                       ed disease burden 3.3 million DALYs 50,000 deaths year [6], making
                                                       leishmaniasis second lethal parasitic infection malaria [5].  treatment
                                                       options limited; recent progress development single-dose
                                                       amphotericin B therapy India [7], treatment regimen effective East Africa
                                                       [8]. drugs require long treatment regimens; toxicity drug resistance sig-
                                                       nificant concerns [9].
                                                           Cell membrane sterols regulate membrane fluidity contribute organization                                                        membrane domains. Unlike mammalian cells, similar fungi, Leishmania Trypano-
                                                       soma parasite cell membranes contain ergosterol ergosterol-like sterols choles-
                                                       terol. Sterols generated acetyl-CoA multistep metabolic pathway.                                                        steps, catalyzed acetoacetyl-CoA thiolase, HMG-CoA synthase HMG-CoA reductase,
                                                       lead generation mevalonate. Mevalonate substrate isoprenoid pathway
                                                       generates farnesyl diphosphate. Squalene synthase produces squalene farne-
                                                       syl diphosphate molecules. Squalene oxidized squalene oxidase, resulting product
                                                       cyclized lanosterol. Sterol 14alpha-demethylase (CYP51, LdBPK_111100.1) catalyses 


PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588            March 13, 2015                                                        2 / 17
                                                                                                      Essentiality Leishmania donovani CYP51



                                            removal 14alpha-methyl group lanosterol [10,11]. L. infantum CYP51 enzyme
                                            broad substrate specificity, ability demethylate obtusifoliol, C4-norlanosterol
                                            14α-methylzymosterol, addition lanosterol, preference                                             substrates [12]. following steps differ ergosterol cholesterol biosynthesis,
                                            variations reaction intermediates enzymes involved depending species [13].
                                            key steps ergosterol biosynthesis methylation C24 sterol
                                            24-methyltransferase, leading formation fecosterol, episterol 5-dehydroepisterol
                                            depending substrate [14].
                                                Azole antifungals investigated treatment Leishmania infections,                                             large variations efficacy species [15]. experiments azole sensitivity                                             visceral Leishmania species showed efficacy ketoconazole [16] oxiconazole [17] 
                                            tracellular amastigotes ketoconazole extracellular promastigotes [18]. Posaconazole
                                            [19] ketoconazole [20] effective mouse models visceral leishmaniasis, albeit
                                            amphotericin B pentavalent antimonial compounds currently used visceral
                                            leishmaniasis treatments. Azoles extensively tested cutaneous Leishmania
                                            species  instance [21,22,23,24] early work parasites). Given importance
                                            CYP51 drug target severity disease caused L. donovani, investigated                                             essentiality L. donovani CYP51 biological pharmacological methods.


                                            Materials Methods
                                            Ethics statement
                                            vertebrate animal studies performed accordance USDA Animal Welfare
                                            Act Guide Care Use Laboratory Animals National Institutes                                             Health. protocol approved University California San Francisco Institutional
                                            Animal Care Use Committee (protocol AN087316). Euthanasia performed carbon
                                            dioxide inhalation followed cervical dislocation.


                                            Cell culture infection
                                            L. donovani 1S/Cl2D promastigotes maintained 26°C M199 medium (Sigma) sup-
                                            plemented 10  heat inactivated fetal bovine serum (FBS, Sigma), 25 mM HEPES, penicil-
                                            lin, streptomycin, adenosine, glutamine, hemin, folic acid pH 7.2. Axenic amastigote
                                            differentiation performed described [25]: promastigotes resuspended amasti-
                                            gote media (M199 medium supplemented 25  FBS, streptomycin, penicillin, succinic
                                            acid, adenine, glycerol, L-proline folic acid, pH 5.5) cell density 5x106 cells/mL
                                            transferred 37°C, 5  CO2.
                                                 THP-1 macrophages maintained RMPI 1640 media supplemented 5  FBS 1 
                                            penicillin-streptomycin 37°C, 5  CO2. Leishmania infection, THP-1 cells treated
                                            50 ng/mL phorbol 12-myristate 13-acetate (PMA) 48 h infected station-
                                            ary phase promastigotes. Cells fixed 4  formaldehyde stained                                             40 ,60 -diamidino-2-phenylindole (DAPI). Images obtained automated InCell 2000
                                            automated imaging (G.E. Healthcare) parasite levels determined using CELL
                                            developer 1.9 software  S1 Methods), leading determination cell boundaries                                             counting parasite inside boundary outside nucleus automated fashion.
                                                 Female BALB/c mice (17–20 g, 6 group) purchased Simonsen Laboratories
                                            maintained animal care facility pathogen-free conditions. Mice infected
                                            intravenously tail vein 5x107 stationary phase promastigotes sacrificed 28 days
                                            post- infection. Liver parasite burden determined direct counting amastigotes 


PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588   March 13, 2015                                                     3 / 17
                                                                                                      Essentiality Leishmania donovani CYP51



                                            Diff-Quick stained liver impressions calculated Leishman-Donovan Units (LDU): num-
                                            ber amastigotes 1000 cell nuclei × liver weight (g).


                                            Generation transfected L. donovani lines
                                            sequences retrieved TriTrypDB [26]. 30 L. donovani CYP51 flanking sequences
                                            amplified PCR parasite genomic DNA (LdBPK_111100.1, primers 1 2),
                                            digested SpeI XbaI, ligated XbaI site vectors pGEM-PAC pGEM-
                                            Hyg. 50 CYP51 flanking region amplified primers 3 4, digested SpeI XbaI,
                                            ligated SpeI site vectors containing CYP51 30 flanking region.
                                            Knockout cassettes liberated restriction enzyme digestion SpeI XbaI.                                             CYP51 coding region amplified PCR genomic DNA (primers 5 6), digested
                                            BglII ligated BglII site pXNG4 vector [27]. cases, constructs                                             verified diagnostic digest sequencing.
                                                Transfection performed described [28] electroporation cytomix transfection
                                            buffer (120mM KCl, 0,15mM CaCl2, 10mM K2HPO4, 25mM HEPES, 2mM EDTA, 2mM
                                            MgCl2) using BioRad Gene Pulser Xcell, delivering pulses 1500 V 25 μF. Parasites
                                            transfected hygromycin knockout cassette; HKO clonal lines selected
                                            100 μg/ml hygromycin (Invitrogen), transfected pXNG4 vector                                             pXNG4 vector encoding CYP51, generating HKO + C HKO + CYP lines,
                                            respectively. Double transfectants maintained combination hygromycin 100
                                            μg/ml nourseothricin (GoldBio). HKO + C HKO + CYP lines transfected pu-
                                            romycin knockout cassette clonal HKO + C + PAC HKO + CYP + PAC lines isolated
                                            limiting dilution selection hygromycin, nourseothricin 20 μg/ml puromycin
                                            (Sigma). Correct targeting CYP51 genes verified PCR using primers 7  CYP51
                                            50 UTR) 8  hygromycin resistance gene) 9  puromycin resistance gene). Persistence
                                            CYP51 genes double resistant, uncomplemented strains loss chromosomal CYP51
                                            complemented strains verified PCR (primers 10 + 11 primers 12 + 13, respec-
                                            tively). Primer 12 upstream CYP51, outside knockout cassette, primer 13 
                                            neals CYP51 gene.


                                            Ganciclovir selection
                                            50 μg/mL ganciclovir (Invivogen) added parasite cultures. qPCR extracted DNA
                                            monitor pXNG4 loss flow cytometry analysis assess GFP levels performed week-
                                            ly  . Results shown represent average independent selection experiments
                                            total seven independent clonal lines.


                                            Quantitative PCR
                                            DNA extracted described previously [29]. qPCR reactions containing 100 ng parasite
                                            DNA Lightcycler 480 Sybr green Master mix (Roche) run Stratagene Mx3005P
                                            RT-PCR thermocycler using following thermal profile: initial denaturation 95°C                                             10 min, 40 cycles denaturation 95°C 10 s, annealing 57°C 20 s extension
                                            72°C 20 s. Melting curve analysis agarose gel electrophoresis used confirm
                                            correct PCR product formation. Chromosomal CYP51 (primers 14 15), total CYP51 (prim-
                                            ers 16 17), pXNG4 (primers 18 19) relative levels determined qPCR using
                                            2-ΔΔCt method [30], normalizing serine acetyltransferase (SAT, primers 20 21)                                             cystathionine beta-synthase (CBS, primers 22 23), previously shown present                                             copies L. donovani [31].



PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588   March 13, 2015                                                     4 / 17
                                                                                                       Essentiality Leishmania donovani CYP51



                                            Flow cytometry
                                            Analyses performed BDFACSDiva LSRII flow cytometer HTS mode. Cells                                             stained 5 μM propidium iodide (PI, Sigma). Quadrant gates set used PI-stained
                                            wild-type parasites (GFP-negative) percentage GFP+ PI- cells determined using FloJo X
                                            software (Tree Star .

                                            SDS PAGE Western blot
                                            1x107 parasites lysed 1x LDS buffer (Invitrogen) separated using NuPage bis-tris
                                            precast polyacrylamide gels (Invitrogen). Proteins transferred PVDF membrane
                                            (BioRad). Western blot performed described [32]. Affinity-purified anti-CYP51 anti-
                                            bodies (Genescript) anti-GAPDH antibody  Paul Michels, Université catholique                                             Louvain, Bruxelles) used 1:5,000 dilution. secondary antibody 1:5,000 dilu-
                                            tion peroxidase-conjugated anti-rabbit IgG antibody (GE Healthcare). proteins vi-
                                            sualized using SuperSignal West Pico Chemoluminescent Substrate (Thermo Scientific).
                                            Proteins expression levels quantified Image J program, normalizing CYP51 levels                                             GAPDH levels.

                                            Sterol GC-MS
                                            Sterol extraction performed described [33]. Briefly, parasite cell pellet resus-
                                            pended chloroform-methanol solution (2:1 ratio), dried nitrogen gas, followed
                                            overnight treatment chloroform. organic phase washed water                                             dried nitrogen. dried pellet resuspended chloroform-methanol (9:1 ratio),
                                            washed water. Acetonitrile added samples, washing steps 
                                            peated solvents evaporated nitrogen.
                                               Extracted sterols derivatized resuspending dried residue 25 μL hexanes
                                            75 μL BSTFA (Sigma-Aldrich, St. Louis MO) 2 hr 37°C generate trimethylsilyl
                                            (TMS) sterols. TMS-derivatized sterols analyzed using gas chromatography-mass spec-
                                            trometry (GC-MS) Agilent HP 6850 GC coupled mass selective detector (Agilent
                                            MSD 5973) operating 70 eV electron impact mode. sterols separated using                                             DB5-MS analytical column (30 m x 0.25 mm inner diameter, 0.25-μm film thickness, Agilent)
                                            temperature profile begins 200°C 1 min, increases 15°C/min 300°C,
                                            holds 300°C 20 min. inlet detector temperatures held 200                                             250°C, respectively. MSD set scan range 50–750 m sterol profiling. Selected
                                            Ion Monitoring (SIM) used ergosterol quantification using GC tempera-
                                            ture profile assaying fragment ions specific ergosterol elute time win-
                                            dow ergosterol standard: m 468.4, 378.4, 363.4, 337.4, 253.1 prepared 8-point
                                            standard curve ergosterol using serial dilution concentration range 9 pmol 1.2
                                            nmoles. area curve SIM assay compared standard samples                                             calculate ergosterol concentrations.

                                            Ergosterol biosynthesis inhibitor assay
                                            Amphotericin B, ketoconazole voriconazole purchased Sigma. CYP51
                                            inhibitors synthesized house  supplementary methods [34,35,36]). Stationary
                                            phase promastigotes (8x105/mL) treated 72 h fold dilution inhibitors                                             384 plate format. Resazurin (0.025 mg/mL, Santa Cruz) added 5 h, cells fixed,
                                            fluorescence measured 490 nm excitation 595 nm emission wavelengths. Data                                             normalized amphotericin B positive control DMSO vehicle negative control 


PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588   March 13, 2015                                                      5 / 17
                                                                                                      Essentiality Leishmania donovani CYP51



                                            plate, EC50 values calculated using Collaborative Drug Discovery Vault software. T. cruzi
                                            cell-based activity determined high content screening triplicate, previously 
                                            scribed [36].


                                            Results
                                            Leishmania donovani tolerate modulations CYP51 levels
                                            generated half knockout L. donovani parasites (HKO strains) single CYP51 allele
                                            replaced puromycin hygromycin resistance marker (Fig. 1A; Fig. 2B                                             knockout approach). CYP51 located chromosome 11, disomic reference
                                            L. donovani genomes [37], trisomic clinical L. donovani isolates [31]. addition,
                                            Leishmania genome contains direct indirect repeats promote extrachro-
                                            mosomal element formation drug pressure essential genes [31,38]. Prior target-
                                            ing CYP51 allele, verified CYP51 copy number parasites transfected
                                            knockout cassette, resistant hygromycin (HygR HKO strains) puro-
                                            mycin (PAC HKO strains). HKO strains contained half CYP51 DNA content                                             wild-type, indicating loss alleles (Fig. 1B). Furthermore, CYP51 protein levels
                                            decreased fold half knockout strains. Complementation episomal
                                            CYP51 gene restored protein expression levels comparable wild-type L. donovani
                                            (Fig. 1C).
                                               Given importance ergosterol biosynthesis trypanosomatid parasites, assessed
                                            impact loss CYP51 expression proceeding targeting second
                                            CYP51 allele. vivo vitro infectivity comparable strains (Fig. 1D, Fig. 1E,
                                            S1 Fig); differences wild-type transfected strains changes                                             CYP51 levels infectivity HKO, HKO+C HKO+CYP comparable. strains
                                            comparable sterol profiles (Fig. 1F) ergosterol levels (Table 1).


                                            Essentiality CYP51: Biological approach
                                            L. donovani parasites able tolerate fold reductions CYP51 protein lev-
                                            els apparent effects parasite phenotype, proceeded targeting second
                                            CYP51 allele.  obtained correct targeting CYP51 hygromycin pu-
                                            romycin resistance markers, double drug-resistant parasites retained CYP51, despite multi-
                                            ple targeting attempts (Fig. 2A). used facilitated knockout approach (Fig. 2B)
                                            [27,39,40], targeting second CYP51 allele presence episomal CYP51 complementa-
                                            tion. control, targeted second allele parasites transfected pXNG4
                                            vector [27] (S2 Fig.). obtained complete loss chromosomal CYP51 genes pres-
                                            ence episomal CYP51; genomic CYP51 retained parasites transfected                                             plasmid, supporting essentiality CYP51 (Fig. 2C).
                                                pXNG4 vector used complementation encodes green fluorescence protein
                                            gene (GFP) herpes virus thymidine kinase gene; cells contain plasmid sensi-
                                            tive treatment ganciclovir (GCV). performed negative selection                                             pXNG4 vector treating transfected parasites GCV. Plasmid persistence                                             GCV treatment monitored qPCR flow cytometry GFP. pXNG4 plasmid
                                            lost faster parasites transfected vector (retain chromosomal
                                            CYP51) parasites transfected vector encoding CYP51  source                                             CYP51), indicating selection CYP51 persistence (Fig. 2D, 2E). clonal line (HKO1 +
                                            CYP + PAC2) showed greater loss pXNG4 plasmid, retained CYP51 DNA levels
                                            comparable half knockout strains, 2^(-ΔΔCt) values 0.6, leading ergosterol levels



PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588   March 13, 2015                                                     6 / 17
                                                                                                               Essentiality Leishmania donovani CYP51




Fig 1. Modulation CYP51 levels L. donovani.  Replacement CYP51 allele homologous recombination. Correct targeting knockout
cassettes verified PCR using primer knockout cassette upstream CYP51 (primers 7 8 (hygromycin), 7 9
(puromycin), . B, qPCR quantification chromosomal CYP51 levels, normalized SAT CBS wild-type levels. C, CYP51 protein levels half knockout complemented strains. CYP51 GAPDH detected Western blot   quantified densitometry   D, vitro
infectivity half knockout complemented strains. THP1 macrophages infected 10:1 parasite macrophage ratio. Cells fixed stained




PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588      March 13, 2015                                                              7 / 17
                                                                                                              Essentiality Leishmania donovani CYP51


 DAPI 24, 48 72 h post-infection, macrophage infection levels determined automated high-throughput imaging parasite detection. E, vivo infectivity half knockout complemented strains. BALB/c mice infected intravenously. Liver parasite burden (Leishman-Donovan Units,
LDU) determined 28 days post-infection counting stained liver impressions. F, Sterol profiling GC-MS.
doi:10.1371/journal.pntd.0003588.g001

                                              similar wild-type, 7 weeks GCV selection (S4 Fig). Overall, results support
                                              essentiality CYP51 L. donovani.

                                              Essentiality CYP51: Pharmacological approach
                                              persistence CYP51-encoding pXNG4 plasmids GCV negative selection indi-
                                              cates CYP51 essential L. donovani. Pharmacological inhibition CYP51                                               lead parasite growth arrest death. 4-aminopyridyl-based compound series
                                              CYP51 inhibitors derived initial hit target-based high-throughput screening,
                                              followed hit lead optimization using structure-activity relationships (SAR), structure-
                                              property relationships (SPR), biological structural evaluation T. cruzi CYP51
                                              [34,35,36,41,42,43,44]. tested 205 compounds series wild-type intracellular L.
                                              donovani amastigotes high content assay. Fifty compounds 60  activity                                               10 μM used dose-response experiments wild-type L. donovani promastigotes
                                              strains modulated CYP51 expression (HKO, HKO+C HKO+CYP). Rep-
                                              resentative compounds highest activity promastigotes shown Fig. 3, Fig. 4.
                                              Activity intracellular amastigotes shown S3 Table. clear difference EC50 values
                                              observed strains ketoconazole voriconazole controls, possibly                                               lower activity L. donovani. house compounds potent assay                                               commercial antifungal azoles. Overall, HKO+CYP strains sensitive 4-
                                              aminopyridyl-based inhibitors compared HKO+C, indicating compounds inhibit
                                              Leishmania growth CYP51-mediated mechanism. confirms targeting CYP51
                                              pharmacologically promotes inhibition parasite growth, supporting essentiality                                               CYP51 L. donovani metabolism.

                                              Discussion
                                              CYP51 (sterol 14alpha-demethylase) belongs large cytochrome P450 enzyme family,
                                              contains 20,000 members. significant variation sequence level,
                                              CYP51 highly conserved eukaroytes structural level [45].  small varia-
                                              tions species strains lead significant variations sensitivity CYP51 
                                              hibitors.  single amino acid change CYP51 T. cruzi Y strain compared                                               Tulahuen strain associated significant decrease sensitivity CYP51 inhibitors,
                                              concentrations caused 100  inhibition Tulahuen enzyme [46].
                                                  vitro side comparison azole efficacy promastigotes Leishmania
                                              species provides conflicting results: studies observed increased susceptibility different
                                              L. donovani strains ketoconazole itraconazole compared different L. major strains
                                              [14,18], studies different L. donovani L. major strains indicated L.
                                              donovani resistant ketoconazole [47] posaconazole [19] L. major. sepa-
                                              rate study, intracellular L. donovani amastigotes sensitive ketoconazole                                               amastigotes cutaneous leishmaniasis patients [16]. L. major promastigotes 
                                              sensitive 4-aminopyridyl-based compound series CYP51 inhibitors, lon-
                                              ger exposure compounds (S2 Table). regards clinical trials, azoles shown
                                              large variations clinical efficacy Leishmania species, effect 90 
                                              efficacy [15], majority studies focused cutaneous leishmaniasis.
                                              single case report successful posaconazole use treat cutaneous



PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588     March 13, 2015                                                             8 / 17
                                                                                                                Essentiality Leishmania donovani CYP51




Fig 2. Essentiality CYP51 L. donovani.  Persistence CYP51 gene correct targeting knockout cassettes CYP51 locus.
Correct targeting knockout cassettes verified PCR using primer knockout cassette upstream CYP51 (primers 7 8
(hygromycin) 7 9 (puromycin)). CYP51 amplified primers coding region (primers 10 11). B, Targeting strategy. Primers 7 8 7 9 expected PCR product sizes confirm correct targeting chromosomal CYP51 alleles indicated arrows (step 4). C, Loss chromosomal CYP51 presence episomal CYP51 complementation strains complemented vector. PCR performed




PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588       March 13, 2015                                                              9 / 17
                                                                                                                   Essentiality Leishmania donovani CYP51



using primers 12+13. D, pXNG4 loss monitored qPCR GCV selection absence positive negative selection (untreated samples).
pXNG4 Ct values normalized SAT levels samples positive selection (treated nourseothricn (NTC) absence GCV). E, GFP
positive, propidium iodide (PI) negative levels monitored flow cytometry. Percentage GFP+ PI- cells normalized levels week 1. *,
p<0.05 compared HKO+CYP+PAC.
doi:10.1371/journal.pntd.0003588.g002

                                               leishmaniasis caused L. donovani infantum [48], knowledge clinical
                                               trial azoles visceral leishmaniasis. Persistent Leishmania growth presence azoles
                                               tied tolerance 14-methyl sterol accumulation parasite membranes [14,18,49]
                                               increased exogenous cholesterol incorporation [18].
                                                   Recent work indicated CYP51 appears dispensable L. major, albeit high fit-
                                               ness cost [14]. contrast, given (1) inability fully knockout chromosomal CYP51 unless
                                               provide extrachromosomal episomal source CYP51, (2) persistence CYP51
                                               episome negative selection conditions source CYP51,
                                               (3) CYP51-specific growth inhibition 4-aminopyridyl-based non-azole CYP51 
                                               hibitors L. donovani, results support essentiality CYP51 L. donovani. extra-
                                               chromosomal episomal-encoded CYP51 fully complement knockout phenotype,
                                               active, given ability substitute chromosomal CYP51 increase 
                                               sistance 4-aminopyridyl-based non-azole CYP51 inhibitors directly target                                                CYP51 active site [13,34,36].
                                                   L. donovani L. major CYP51 overall similar. Comparing L. major L.
                                               donovani CYP51 protein sequences highlights amino acid substitutions β helices 1–1
                                               1–2 single amino acid insertion C-terminal L. donovani compared                                                L. major (S5 Fig). suggests mechanisms responsible observed dif-
                                               ferences CYP51 essentiality L. major L. donovani.  squalene synthase,
                                               catalyzes committed step ergosterol biosynthesis, involved resis-
                                               tance itraconazole [50]; differences sensitivity squalene synthase inhibitors                                                observed L. major L. donovani [51]. Likewise, differences sensitivity
                                               sterol 24-methyltransferase inhibitors L. major L. donovani [52]. Finally,                                                activity L. donovani 3-hydroxy-3-methylglutaryl coenzyme reductase (HMG-CoA reduc-
                                               tase) 50-fold higher activity L. major enzyme [53]. HMG-CoA reductase


                                               Table 1. Ergosterol levels half knockout strains.

                                               Stage                                              Strain                          Ergosterol levels (pmol                                                Promastigotes                                      Wild-type                       7236.7
                                                                                                  HKO                             5167.3
                                                                                                  HKO + C                         7535.2
                                                                                                  HKO + CYP                       5887.9
                                               Axenic amastigotes                                 Wild-type                       1374.7
                                                                                                  HKO                             1102.8
                                                                                                  HKO + C                          904.4
                                                                                                  HKO + CYP                        983.3
                                               Intracellular amastigotes                          Wild-type                        135.2
                                                                                                  HKO                              165.3
                                                                                                  HKO + C                          462.0
                                                                                                  HKO + CYP                        327.7
                                                                                                  Normalized host cholesterol levels intracellular amastigotes

                                               doi:10.1371/journal.pntd.0003588.t001




PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588           March 13, 2015                                                         10 / 17
                                                                                                        Essentiality Leishmania donovani CYP51




Fig 3. Susceptibility half knockout strains CYP51 inhibitors (EC50, μM): compounds significant differences HKO + C HKO + CYP strains. Values ± standard error shown. p-values comparison HKO+C HKO+CYP.
doi:10.1371/journal.pntd.0003588.g003

                                            catalyzes step sterol synthesis acetyl-CoA rate-limiting step                                             human sterol biosynthesis [54]. Finally, member cytochrome P450 family,
                                            CYP5122A1 (LdBPK_270090.1), modulates ergosterol levels L. donovani [55]; ex-
                                            pression activity altered CYP51-deficient L. major, complement loss                                             CYP51.
                                               differences CYP51 sterol biosynthetic pathways L. major                                             L. donovani, additional factors contribute observed difference CYP51




PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588   March 13, 2015                                                      11 / 17
                                                                                                        Essentiality Leishmania donovani CYP51




Fig 4. Susceptibility half knockout strains CYP51 inhibitors (EC50, μM): compounds decreased activity HKO + CYP strains. Values ±
standard error shown. p-values comparison HKO+C HKO+CYP.
doi:10.1371/journal.pntd.0003588.g004



                                            essentiality.  Xu et al showed L. major CYP51 involved protection heat
                                            shock [14]. L. major considerably sensitive heat shock L. donovani,                                             mechanism resistance heat shock differs species, L. donovani-spe-
                                            cific A2 protein family key contributor L. donovani survival heat stress [25,32].
                                            Likewise, gp63 lipophosphoglycan levels altered CYP51-deficient L. major [14].
                                            Lipophosphoglycan structurally different L. major L. donovani [56], gp63
                                            members L. donovani species complex active L. major gp63 [57].




PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588   March 13, 2015                                                      12 / 17
                                                                                                       Essentiality Leishmania donovani CYP51



                                               Overall, results support investigation CYP51 inhibitors treatment vis-
                                            ceral leishmaniasis. recent clinical trial results using posaconazole treatment                                             Chagas disease disappointing [58], enhanced potency observed L. donovani 4-
                                            aminopyridyl-based non-azole inhibitors CYP51 compared ketoconazole voriconazole
                                            supports development novel inhibitor scaffolds, potentially using 4-aminopyridyl 
                                            hibitor series starting point. Given lower efficacy inhibitors Leishmania com-
                                            pared T. cruzi, efforts medicinal chemistry optimize                                             pharmacodynamic pharmacokimetic properties compounds activity                                             Leishmania. particular, efficacy lower intracellular wild-type L. donovani amas-
                                            tigotes compared transfected promastigote strains (S3 Table), possibly additional
                                            constraints regards drug uptake host cell parasite-containing acidic
                                            phagolysosome. Finally, work work indicate CYP51-targeted therapies
                                            suitable treat Leishmania species. highlights importance considering
                                            variations species strains early drug development process.


                                            Supporting Information
                                            S1 Methods. Supplemental methods.
                                            (DOC)
                                            S1 Scheme. Synthesis CYP51 inhibitors. Reagents conditions:   Arylboronic acid,
                                            5 mol  Pd2(dba)3, 10 mol  PCy3, 2M K3PO4, dioxane, 100°C (microwave), 1h, ca. 90  (b)
                                            1-(aryl)piperazine, Pd(OAc)2, P(o-tolyl)3, Cs2CO3, toluene, 50°C, 48 h, ca. 70  (c) 10  NaOH
                                            (aq), MeOH/THF (1/1), 60°C, 3 h, ca. 95  (d) 11, 12, 13, 14, 15, 16, 17, 18b, 19b, 20b                                              appropriate), PyBOP, HOBt, Et3N, CH2Cl2, 23°C, 1h, ca. 50 .
                                            (PPT)
                                            S1 Fig. vitro infectivity half knockout complemented strains. THP1 macrophages
                                            infected 10:1 parasite macrophage ratio. Cells fixed stained DAPI
                                            24, 48 72 h post-infection, parasite numbers infected cell determined auto-
                                            mated high-throughput imaging parasite detection
                                            (PPT)
                                            S2 Fig. Targeting hygromycin puromycin resistance knockout cassettes. Correct tar-
                                            geting hygromycin   puromycin (B) resistance knockout cassettes verified                                             PCR using primer upstream CYP51 specific resistance marker (primers 7
                                            8 (hygromycin) 7 9 (puromycin)). HKO1 + CYP + PAC clones 2, 4, 5; HKO2 + C +
                                            PAC clones 1, 2 3; HKO2 + CYP + PAC clones 1, 2, 4 5 correct targeting                                             knockout cassettes.
                                            (PPT)
                                            S3 Fig. Representative flow cytometry analysis weeks GCV selection. Parasites
                                            treated NTC (positive selection), GCV (negative selection) left untreated (-NTC-
                                            GCV) weeks. representative cell line shown HKO + C + PAC HKO +
                                            CYP + PAC.  Quadrant analysis. Numbers indicate percentage cells quadrant.
                                            B, Representative GFP histogram plots PI-negative cells. Wild-type parasites (dotted line)
                                            serve non-fluorescent cutoff reference. Black, NTC treatment (positive selection). Grey,
                                            GCV treatment (negative selection).
                                            (PPT)
                                            S4 Fig. Persistence CYP51 HKO1 + CYP + PAC2 strain. CYP51 persistence 
                                            sessed qPCR   Western blot (B) following seven weeks GCV selection. Sterol



PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003588   March 13, 2015                                                     13 / 17
                                                                                                             Essentiality Leishmania donovani CYP51



                                            profiles ergosterol levels determined GC-MS (C). Chol., cholesterol.
                                            Erg, ergosterol.
                                            (PPT)
                                            S5 Fig. Alignment L. major L. donovani CYP51.  Clustal Omega alignment. β 1–1
                                            1–2 helices positioned [12]. B, Secondary structure alignment. 3-D models L.
                                            major L. donovani CYP51 generated using TASSER server. scoring
                                            models overlaid using UCSF Chimera. Red, L. donovani. Blue, L. major.
                                            (PPT)
                                            S1 Table. Oligonucleotides used study.
                                            (XLS)
                                            S2 Table. Susceptibility L. major CYP51 inhibitors (EC50, μM).
                                            (DOC)
                                            S3 Table. Susceptibility intracellular L. donovani amastigotes select CYP51 inhibitors.
                                            (DOC)

